Seroba Life Sciences β Full Portfolio
31 tracked investments Β· listed companies and verified rows first
Loci Orthopaedics develops extremity orthopaedic technologies, including its InDx device for the thumb base joint, using evidence-based design to address unmet clinical needs.
HealthtechMedical DevicesGalway, IE
Brendan Boland(Co-founder & Executive Chairperson)Barry(CEO)Paul(Finance Leader)John(VP Technical Operations)Karin(Medical Affairs / Clinical Development)Gerry(Co-founder)
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)Pietro Faccioli(Co-founder)Giovanni Spagnolli(Co-founder, CTO)Maria Letizia Barreca(Co-founder)Graziano Lolli(Co-founder)
BiotechPhiladelphia, US
Raj Kannan(Executive Officer, Director)
BoardClaudio Nessi(Director)Ivan Gergel(Director)Jan Van de Bossche(Director)Garrett Ingram(Director)Gregory Parekh(Director)
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)Muhammad Ali Memon(Chief Medical Officer)
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery sensor and remote monitoring platform for managing NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Jonathan Jonas(Director)Harry Rowland(Executive Officer, Director)Raymond S. Barrett, Jr.(Director)Anthony I Nunez(Executive Officer, Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)Liam Mullins(CTO and Co-founder)
HealthtechSunnyvale, US
Richard Ferrari(Executive Officer, Director)David Neustaedter(Director)Kenneth Hayes(Director)James Joye(Executive Officer, Director)Chris Owens(Director)
BoardDaniel O'Mahony(Director)
PrecisionBiotics develops food supplements containing specific bacterial strains aimed at supporting gut health and the microbiome for consumers and clinicians, alongside educational resources on gut health.
BiotechConsumerHealthtechWellness & Fitness
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions.
BiotechHealthtechMedical DevicesCopenhagen, DK
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities.
HardwareHealthtechMedical DevicesBurbank, US
ERIC RICE(Executive Officer)JEFFREY DOIRON(Executive Officer)BLAKE GILETTE(Executive Officer)KIRK WESTWOOD(Executive Officer)
Ryme Medical develops a catheter-based therapy to treat chronic obstructive pulmonary disease (COPD) by reducing airway inflammation and improving patient outcomes.
BiotechHealthtechMedical DevicesMountain View, US
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)Zack Scott(Director)Brad Vale(Director)Casey Tansey(Director)Mudit Jain(Executive Officer, Director)
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.